U.S. Online Retail and Ecommerce Stock News

Alkermes plc recently announced that the FDA granted Breakthrough Therapy designation to alixorexton, its investigational oral orexin 2 receptor agonist, for treating narcolepsy type 1, based on positive phase 1 and phase 2 data from the Vibrance-1 trial. This designation spotlights alixorexton’s potential to address persistent unmet needs in narcolepsy type 1 and could accelerate development of Alkermes’ broader orexin agonist program across sleep-related disorders. With alixorexton now...

Why AMD stock is back in focus for investors Advanced Micro Devices (AMD) is drawing attention again as investors weigh its recent share performance, including a 1.7% move over the past day, against longer term returns and the company’s current earnings profile. See our latest analysis for Advanced Micro Devices. The recent 7 day share price return of 11.62% and 30 day share price return of 8.62%, against a 90 day share price return of a 2.60% decline, suggests momentum has picked back up...

In early January 2026, Zymeworks reported positive Phase 3 HERIZON-GEA-01 results for its HER2-targeted therapy Ziihera in advanced gastroesophageal adenocarcinoma, alongside a series of leadership changes including new board and executive appointments and key retirements. A distinctive angle in this news is that the HERIZON-GEA-01 data could unlock up to US$440.0 million in potential approval-related milestones for Ziihera across the US, Europe, Japan, and China, adding financial...

As the U.S. market grapples with rising Treasury yields and uncertainty surrounding Federal Reserve decisions, investors are keenly observing potential opportunities amid recent index declines. In this environment, identifying undervalued stocks can be crucial for those looking to capitalize on discrepancies between market price and estimated value, as these stocks might offer growth potential despite broader economic challenges.

Micron Technology has strategically moved to acquire Powerchip Semiconductor Manufacturing Corporation’s P5 fabrication site in Tongluo, Taiwan, for $1.8 billion, aiming to enhance its global presence in the memory solutions sector. This acquisition, including a sizable 300,000 square feet of cleanroom space, positions Micron to meet the increasing global demand for memory by boosting DRAM production capabilities. The initiative aligns with Micron's broader expansion plans and will establish...

As U.S. markets face weekly losses amid climbing Treasury yields, investors are increasingly focused on companies with strong fundamentals and insider confidence to navigate these uncertain times. In this landscape, growth companies with high insider ownership stand out, as they often signal management's belief in the firm's potential and align interests between executives and shareholders.

As the U.S. markets grapple with recent declines and rising Treasury yields, investors are keenly observing potential opportunities in various sectors. Penny stocks, while often seen as relics of past market trends, continue to offer intriguing possibilities for those willing to explore smaller or newer companies at accessible price points. By focusing on solid financials and growth potential, these stocks can present unique opportunities for investors looking to tap into under-the-radar...

As the U.S. market grapples with rising Treasury yields and a cautious Federal Reserve outlook, small-cap stocks are navigating a landscape marked by both challenges and opportunities. In this environment, identifying promising small caps requires a keen eye for companies with robust fundamentals that can weather economic fluctuations and capitalize on niche market demands.

The recent 11% drop in AIFU Inc.'s ( NASDAQ:AIFU ) stock could come as a blow to insiders who purchased CN¥12.3m worth...

We're definitely into long term investing, but some companies are simply bad investments over any time frame. It hits...

In recent days, multiple research firms, including Barclays and Evercore ISI, have reiterated coverage on Werner Enterprises while revising their views on the company’s prospects and positioning in the trucking and logistics market. The mix of “Hold” and “Underperform” ratings alongside more optimistic outlooks highlights how differently analysts interpret Werner’s operational trajectory and profitability challenges. We’ll now examine how this broad reassessment by major analysts could...

Textron (TXT) is back in focus after strong aerospace and defense results, active analyst commentary, and fresh institutional repositioning, with interest further supported by new aircraft products entering service featuring advanced Garmin Autothrottle technology. See our latest analysis for Textron. The recent aerospace and defense contract wins, product milestones and mixed analyst commentary are landing against a constructive backdrop, with a 90-day share price return of 13.5% and a...

In recent days, Scotiabank and several other research firms shifted their views on American Homes 4 Rent, updating ratings and reassessing their outlook on the single‑family rental REIT. This cluster of analyst actions offers fresh information on how the market is reassessing American Homes 4 Rent’s risk‑reward profile and business outlook. Next, we’ll examine how this wave of analyst rating changes could influence American Homes 4 Rent’s investment narrative and future expectations. Rare...

AAR (AIR) is back in focus after reporting second quarter results, outlining new guidance, and advancing its acquisition pipeline, all alongside fresh progress on distribution partnerships and an almost fully executed share repurchase program. See our latest analysis for AAR. The latest news around earnings, M&A plans, and the near complete buyback sits alongside a 30 day share price return of 27.05% and a 1 year total shareholder return of 49.67%. This points to building momentum from both...

Black Hills (BKH) has just energized its 260 mile, US$350 million Ready Wyoming electric transmission expansion, connecting its South Dakota and Wyoming systems and putting new long term infrastructure squarely on investors’ radar. See our latest analysis for Black Hills. That Ready Wyoming milestone lands at a time when momentum in the shares has been building, with a 30 day share price return of 8.65% and a 1 year total shareholder return of 28.60% pointing to investors reassessing both...

BlackRock, Inc. ( NYSE:BLK ) has announced that it will be increasing its dividend from last year's comparable payment...

Earlier this month, Teledyne Technologies’ subsidiary Teledyne FLIR Defense secured a U.S. Army contract worth up to US$32 million to provide advanced electro-optical systems for Bulgaria’s new Stryker armored vehicles as part of a Foreign Military Sales modernization program. The award underscores Teledyne’s role in supplying high-spec thermal imaging, radar, and targeting software that enhance allied NATO forces’ reconnaissance and interoperability capabilities. Next, we’ll examine how...

Oruka Therapeutics (ORKA) drew fresh investor attention after reporting encouraging interim Phase 1 data for ORKA-002, highlighting a long half-life and sustained IL-17 inhibition that could support less frequent dosing in psoriasis and hidradenitis suppurativa. See our latest analysis for Oruka Therapeutics. The positive ORKA-002 readout and recent conference presence appear to have kept interest high, with a 1-day share price return of 2.77% and year to date share price return of 18.15%...

The Morning Bull - US Market Morning Update Monday, Jan, 19 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 0.8%, as investors react to a jump in the US 10 year Treasury yield to 4.23%. A higher government bond yield means borrowing can get more expensive for households and businesses, which often puts pressure on growth and rate sensitive stocks. At the same time, fresh data from China shows 5.0% GDP growth in 2025 but softer retail sales at...

Fresh coverage of Harrow (HROW) is drawing attention to its move from an ophthalmic compounder to an integrated eye care pharma platform, built around acquired FDA-approved drugs and long-run revenue and margin targets. See our latest analysis for Harrow. At a share price of $47.90, Harrow has recently had a softer 1 day share price return of a 1.22% decline. However, its 90 day share price return of 17.34% and 1 year total shareholder return of 41.51% indicate that momentum has been building...

Archrock Inc recently reported a very large year-over-year EPS increase alongside higher profit margins and stronger free cash flow per share, reflecting improving fundamentals and operational efficiency. What stands out is that this combination of earnings strength and rising cash generation has emerged alongside positive technical momentum, suggesting growing investor attention to the company’s profitability profile. With this backdrop of sharply improving earnings, we’ll now explore how...

The Goldman Sachs Group, Inc.'s ( NYSE:GS ) dividend will be increasing from last year's payment of the same period to...

Key Insights Given the large stake in the stock by institutions, Zhihu's stock price might be vulnerable to their...

Key Insights Aptera Motors' significant insider ownership suggests inherent interests in company's expansion A total of...